Pharma & Biotech

An effective monitoring strategy considers factors including the medical condition concerned, the type and complexity of the therapeutic agent, the phase of development and the complexity of the protocol. Our expert team will develop an appropriate strategy, combining close support for the sites and remote activities with on-site visits as required. ClinChoice supports a risk-based approach to monitoring, ensuring efficiency and adherence to regulatory expectations.

Rigorously Monitor Clinical Activities at Every Stage

As the crucial interface between project teams and Investigators, our CRAs demonstrate top clinical monitoring skills to address site-level issues proactively. With rich experience and a robust training program, as well as technology powered by Techorizon, a wholly owned subsidiary of ClinChoice, our CRA team monitors all project parameters for compliance with the protocol and regulatory requirements. Supported by an internal data visualization platform, ClinChoice also implements risk-based monitoring according to industry standards to ensure monitoring activities are focused appropriately on sites or data requiring the most attention.

Robust Training System

ClinChoice prioritizes training to equip every CRA with additional and up-to-date regulatory knowledge and technical prowess. All individuals undertake a personalized training program to ensure they’re well-prepared to provide high-quality services that consistently earn trust and recognition from our partners. This means you can always rely on the quality of the ClinChoice CRAs assigned to your trial.

Flexible Delivery Models

Our CRAs are home-based and strategically located to enhance local language and cultural comprehension while also minimizing travel and inefficiencies. We’ll leverage a delivery model that suits your operational needs to ensure success. In addition to our full-service offering, we provide CRA teams on a per-project or Functional Service Provider (FSP) basis.

Explore Biometrics Solutions